Literature DB >> 25085312

Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view.

Sofia Battisti1, Francesco Maria Guida2, Elisa Pagliara3, Giuseppe Tonini2, Bruno Beomonte Zobel3, Daniele Santini2.   

Abstract

Entities:  

Keywords:  Anti-EGFR therapy; CT scan; Neoadjuvant therapy; Toxicity; mCRC

Mesh：

Substances：

Year:  2014        PMID： 25085312     DOI： 10.1016/j.clcc.2014.06.003

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN： 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  4 in total

1.  Clinical features of pseudocirrhosis in metastatic breast cancer.

Authors:  Caspian Oliai; Michael L Douek; Caelainn Rhoane; Abhishek Bhutada; Phillip S Ge; Bruce A Runyon; Xiaoyan Wang; Sara A Hurvitz
Journal:  Breast Cancer Res Treat       Date:  2019-06-07       Impact factor: 4.872

2.  Pseudocirrhosis: A Case Series and Literature Review.

Authors:  Abimbola Adike; Nina Karlin; Christine Menias; Elizabeth J Carey
Journal:  Case Rep Gastroenterol       Date:  2016-07-29

3.  Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy.

Authors:  Seiichiro Mitani; Shigenori Kadowaki; Hiroya Taniguchi; Hisanori Muto; Kei Muro
Journal:  Case Rep Oncol       Date:  2016-02-06

4.  Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis.

Authors:  Linda Calistri; Vieri Rastrelli; Cosimo Nardi; Davide Maraghelli; Sofia Vidali; Michele Pietragalla; Stefano Colagrande
Journal:  World J Gastroenterol       Date:  2021-12-14       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.